RMD

Q: What is the price of ResMed (RMD) today?

The current price of ResMed (RMD) is $ 228.88, representing a 6.7% gain over the past year. The stock began the year trading around $ 240.87 and is currently priced at $ 228.88. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does ResMed (RMD) pay dividends?

In the last year, ResMed (RMD) distributed dividends in the month of March, totaling $ 0.60. The Dividend Yield for the last 12 months is 1.04%.

Q: Is ResMed (RMD) a good investment?

ResMed (RMD) is currently trading at $ 228.88 with a P/E ratio of 22.02%. This represents a 2,663% premium compared to its historical average P/E. Over the past year, the stock has gained 6.7 and paid $ 0.60 in dividends, resulting in a dividend yield of 1.04%. The total shareholder return over the same period was 6.70%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

ResMed Inc.

Price

$ 228.88

return (12m)

6.70%

p/e

22.02

p/bv

5.18

DIVIDEND YIELD

1.04%

RMD price

RMD

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment RMD

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-7.16%

3 months

-9.13%

1 year

6.70%

2 years

19.95%

5 years

18.51%

10 years

332.49%

Fundamentals RMD

review the fundamentals of ResMed shares

P/E

22.02

Sector: -2.15 Industry: 0.38

P/S (PSR)

6.06

Sector: 1.92 Industry: 2.43

P/BV

5.18

Sector: 2.10 Industry: 2.24

DIVIDEND YIELD (DY)

1.04%

Sector: - Industry: -

ROA

17.47%

Sector: -25.33% Industry: -23.48%

ROE

23.51%

Sector: -29.65% Industry: -31.19%

ROIC

25.34%

Sector: -418.66% Industry: -76.94%

NET MARGIN

27.53%

Sector: -27.82% Industry: -30.15%

GROSS MARGIN

60.87%

Sector: 44.91% Industry: 51.03%

OPERATING MARGIN

34.14%

Sector: -22.85% Industry: -26.89%

EV/EBITDA

15.66

Sector: -0.40 Industry: 1.11

EV/EBIT

17.75

Sector: -1.68 Industry: -0.22

PRICE-TO-ASSETS

3.85

Sector: 1.13 Industry: 1.20

BVPS

43.29

Sector: 3.83 Industry: 5.09

EPS

10.18

Sector: -0.89 Industry: -0.80

EQUITY-TO-ASSETS RATIO

0.74

Sector: 0.44 Industry: 0.46

LIABILITIES / ASSETS

0.26

Sector: 0.46 Industry: 0.50

CAGR REVENUE 5 YEARS

17.10%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

23.27%

Sector: - Industry: -

FAIR VALUE OF ResMed ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 228.88

Fair Value

$ 0.00

Upside/Downside Return potential.

-56.49%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals RMD

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	40.57	35.11	86.53%	0.67%	$ 837.34 B	31.66%
ISRG	56.19	8.94	15.92%	0.00%	$ 160.48 B	28.38%
TMO	27.56	3.45	12.52%	0.35%	$ 184.79 B	15.05%
SNY	12.82	1.39	10.86%	4.62%	$ 116.90 B	18.68%
NVS	21.09	6.34	30.04%	4.53%	$ 294.97 B	24.67%
ABT	27.37	3.48	12.73%	2.34%	$ 178.54 B	14.72%
MDT	24.09	2.26	9.38%	3.27%	$ 111.15 B	13.00%
CVS	52.79	1.24	2.35%	3.62%	$ 93.33 B	0.44%
GSK	14.82	5.29	35.71%	2.96%	$ 113.04 B	17.48%
BSX	32.15	0.00	0.00%	0.00%	$ 93.16 B	14.44%
TMDX	17.99	7.24	40.22%	0.00%	$ 3.42 B	31.43%
HCA	15.86	-38.82	-244.82%	0.62%	$ 107.58 B	8.97%
IDXX	43.01	28.38	65.99%	0.00%	$ 45.56 B	24.62%
DHR	37.39	2.57	6.88%	0.67%	$ 135.12 B	14.71%
INMD	9.26	1.27	13.73%	0.00%	$ 868.77 M	25.32%
PHG	24.85	2.00	8.06%	3.27%	$ 25.78 B	5.07%
FMS	11.36	0.77	6.75%	3.51%	$ 12.82 B	5.02%
SYK	39.12	5.66	14.48%	1.03%	$ 126.98 B	12.92%
CI	10.45	0.00	0.00%	2.26%	$ 71.83 B	2.50%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

RMD Historical Dividends

current DY: 1.04%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	02/12/2026	03/16/2026	0,60000000
Dividends	11/13/2025	12/18/2025	0,60000000
Dividends	08/14/2025	09/18/2025	0,60000000
Dividends	05/08/2025	06/12/2025	0,53000000
Dividends	02/13/2025	03/20/2025	0,53000000
Dividends	11/07/2024	12/12/2024	0,53000000
Dividends	08/15/2024	09/19/2024	0,53000000
Dividends	05/09/2024	06/13/2024	0,48000000
Dividends	02/08/2024	03/14/2024	0,48000000
Dividends	11/09/2023	12/14/2023	0,48000000
Dividends	08/17/2023	09/21/2023	0,48000000
Dividends	05/11/2023	06/15/2023	0,44000000
Dividends	02/09/2023	03/16/2023	0,44000000
Dividends	11/10/2022	12/15/2022	0,44000000
Dividends	08/18/2022	09/22/2022	0,44000000
Dividends	05/12/2022	06/16/2022	0,42000000
Dividends	02/10/2022	03/17/2022	0,42000000
Dividends	11/11/2021	12/16/2021	0,42000000
Dividends	08/19/2021	09/23/2021	0,42000000
Dividends	05/13/2021	06/17/2021	0,39000000
Dividends	02/11/2021	03/18/2021	0,39000000
Dividends	11/12/2020	12/17/2020	0,39000000
Dividends	08/20/2020	09/24/2020	0,39000000
Dividends	05/14/2020	06/18/2020	0,39000000
Dividends	02/13/2020	03/19/2020	0,39000000
Dividends	11/07/2019	12/12/2019	0,39000000
Dividends	08/15/2019	09/19/2019	0,39000000
Dividends	05/09/2019	06/13/2019	0,37000000
Dividends	02/07/2019	03/14/2019	0,37000000
Dividends	11/08/2018	12/13/2018	0,37000000
Dividends	08/16/2018	09/20/2018	0,37000000
Dividends	05/10/2018	06/14/2018	0,35000000
Dividends	02/08/2018	03/15/2018	0,35000000
Dividends	11/09/2017	12/14/2017	0,35000000
Dividends	08/17/2017	09/21/2017	0,35000000
Dividends	05/11/2017	06/15/2017	0,33000000
Dividends	02/09/2017	03/16/2017	0,33000000
Dividends	11/10/2016	12/15/2016	0,33000000
Dividends	08/18/2016	09/22/2016	0,33000000
Dividends	05/19/2016	06/16/2016	0,30000000
Dividends	02/11/2016	03/17/2016	0,30000000
Dividends	11/19/2015	12/17/2015	0,30000000
Dividends	08/20/2015	09/17/2015	0,30000000
Dividends	05/21/2015	06/18/2015	0,28000000
Dividends	02/12/2015	03/19/2015	0,28000000
Dividends	11/20/2014	12/18/2014	0,28000000
Dividends	08/21/2014	09/18/2014	0,28000000
Dividends	05/20/2014	06/17/2014	0,25000000
Dividends	02/19/2014	03/19/2014	0,25000000
Dividends	11/19/2013	12/18/2013	0,25000000
Dividends	08/20/2013	09/17/2013	0,25000000
Dividends	05/21/2013	06/18/2013	0,17000000
Dividends	02/19/2013	03/19/2013	0,17000000
Dividends	11/20/2012	12/18/2012	0,17000000
Dividends	09/07/2012	09/28/2012	0,17000000

ABOUT ResMed

ResMed Inc.

Average Investor10 user rating

4.0 (25 people)

United States

32 years

Founded: 1994

1995

Time since IPO - 31 years

7.770

Employees

ResMed Inc. (United States) is listed on the NYSE and has a market capitalization of $32.72 Billions, with shareholders equity totaling $6.32 Billions.

The company employs approximately 7.770 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, ResMed Inc. reported $5.40 Billions in revenue, generating net income of $1.49 Billion.

Key financial metrics include a P/E ratio of 22.02, a price-to-book (P/B) ratio of 5.18, and a trailing twelve-month dividend yield of 1.04%.

The company trades under the ticker RMD.

Market cap

$ 32.72 Billions

Net worth

$ 6.32 Billions

$ 6,320,880,000.00

Assets

$ 8.50 Billions

$ 8,503,370,000.00

Total Shares Outstanding

146.00 Millions

146,000,000

Average Daily Trading Volume

$ 1.14 Million

$ 1,143,338.46

Sector

Health

Industry

Medical Supplies and Equipment

RMD

revenue by Business Segment ResMed

Revenue by Region ResMed

RMD revenue and profits

Financial Results RMD

DRAG THE FRAME TO SEE MORE DATA

RMD cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 79.16 20,24% (12M)

P/E

52.79

3.62%

ROE

2.35%

P/BV

1.24

CI - Cigna

$ 278.37 --13,14% (12M)

P/E

10.45

2.26%

ROE

0.00%

P/BV

0.00

CNC - Centene

$ 37.27 --40,26% (12M)

P/E

-2.59

0.00%

ROE

-33.28%

P/BV

0.86

HUM - Humana

$ 197.45 --30,67% (12M)

P/E

17.96

1.99%

ROE

6.70%

P/BV

1.20

HCA - HCA Healthcare

$ 510.27 53,37% (12M)

P/E

15.86

0.62%

ROE

-244.82%

P/BV

-38.82

LLY - Eli Lilly

$ 959.08 31,90% (12M)

P/E

40.57

0.67%

ROE

86.53%

P/BV

35.11

NVS - Novartis

$ 155.47 58,82% (12M)

P/E

21.09

4.53%

ROE

30.04%

P/BV

6.34

LBPSW - 4D pharma

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-300.00%

P/VP

0.00

CVS - CVS Health

$ 79.16 20,24% (12 M)

P/L

52.79

3.62%

ROE

2.35%

P/VP

1.24

CI - Cigna

$ 278.37 --13,14% (12 M)

P/L

10.45

2.26%

ROE

0.00%

P/VP

0.00

CNC - Centene

$ 37.27 --40,26% (12 M)

P/L

-2.59

0.00%

ROE

-33.28%

P/VP

0.86

HUM - Humana

$ 197.45 --30,67% (12 M)

P/L

17.96

1.99%

ROE

6.70%

P/VP

1.20

HCA - HCA Healthcare

$ 510.27 53,37% (12 M)

P/L

15.86

0.62%

ROE

-244.82%

P/VP

-38.82

LLY - Eli Lilly

$ 959.08 31,90% (12 M)

P/L

40.57

0.67%

ROE

86.53%

P/VP

35.11

NVS - Novartis

$ 155.47 58,82% (12 M)

P/L

21.09

4.53%

ROE

30.04%

P/VP

6.34

Frequently Asked Questions

What is the price of ResMed (RMD) today?

The current price of ResMed (RMD) is $ 228.88, representing a 6.7% gain over the past year. The stock began the year trading around $ 240.87 and is currently priced at $ 228.88. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does ResMed (RMD) pay dividends?

In the last year, ResMed (RMD) distributed dividends in the month of March, totaling $ 0.60. The Dividend Yield for the last 12 months is 1.04%.

Is ResMed (RMD) a good investment?

ResMed (RMD) is currently trading at $ 228.88 with a P/E ratio of 22.02%. This represents a 2,663% premium compared to its historical average P/E. Over the past year, the stock has gained 6.7 and paid $ 0.60 in dividends, resulting in a dividend yield of 1.04%. The total shareholder return over the same period was 6.70%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy ResMed (RMD) stock?

You can buy ResMed (RMD) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol RMD and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of ResMed (RMD) yield today?

Over the past month, ResMed (RMD) has returned -7.16% — 6.70% over the past year, and 18.51% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 2.33 per share in dividends, resulting in a dividend yield of 1.04%.

If you were to purchase 100 shares of ResMed (RMD) today at the current price of $ 228.88 your total investment would be $ 22,888.00.

Based on historical performance, the investment would have grown to approximately:

$ 24,421.50 after 1 year
$ 27,124.57 after 5 years
$ 98,988.31 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

RMD

ResMed Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment RMD

review the fundamentals of ResMed shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 1.04%

5-year average DY: 0.00%

type

Ex - Dividend Date

payment date

value

ABOUT ResMed

ResMed Inc.

United States

32 years

1995

7.770

PROFIT X PRICE RMD

Financial Results RMD

RMD cash flow

Asset, Revenue and Profit Growth - RMD

RMD balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

HCA - HCA Healthcare

LLY - Eli Lilly

NVS - Novartis

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

HCA - HCA Healthcare

LLY - Eli Lilly

NVS - Novartis

Frequently Asked Questions